The MarketReader Minute
💊 Amgen Falls on Obesity Drug Data; Exact Sciences Soars on Medicare Boost, Viking Therapeutics Gains Momentum | Biotech Sector Insights
(IBB) has declined by 1.6% today, coinciding with a 1.17% drop in the Russell 2000 Index, suggesting broader market sentiment is influencing biotechnology stocks. Among IBB's holdings, Amgen Inc. experienced a significant decline.